Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Ixekizumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eli Lilly`s Biologic Taltz (Ixekizumab) Receives Suppl Approvals in US
    Eli Lilly`s Biologic Taltz (Ixekizumab) Receives Suppl Approvals in US

    19 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125521

    FDA
    19 Aug 2024
    Share Share
    Eli Lilly's Biologic Taltz (Ixekizumab) Receives Approval in the U.S.
    Eli Lilly's Biologic Taltz (Ixekizumab) Receives Approval in the U.S.

    13 Sep 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125521

    FDA
    13 Sep 2023
    Share Share
    Eli Lilly forays into dermatological space with launch of psoriasis drug
    Eli Lilly forays into dermatological space with launch of psoriasis drug

    14 Mar 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/eli-lilly-forays-into-dermatological-space-with-launch-of-psoriasis-drug/articleshow/98625403.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    14 Mar 2023
    Share Share
    Lilly's Taltz Now Available in New, Citrate-Free Formulation
    Lilly's Taltz Now Available in New, Citrate-Free Formulation

    08 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lillys-taltz-ixekizumab-now-available-in-new-citrate-free-formulation-to-reduce-injection-site-pain-for-improved-patient-experience-301601067.html

    PRNEWSWIRE
    08 Aug 2022
    Share Share
    Eli Lilly Taltz (Ixekizumab) Receives Supplemental Approval in the U.S.
    Eli Lilly Taltz (Ixekizumab) Receives Supplemental Approval in the U.S.

    04 May 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125521

    FDA
    04 May 2022
    Share Share
    NICE backs Lilly’s Taltz for axial spondyloarthritis
    NICE backs Lilly’s Taltz for axial spondyloarthritis

    16 Jun 2021

    // PHARMATIMES

    http://www.pharmatimes.com/news/nice_backs_lillys_taltz_for_axial_spondyloarthritis_1371749

    PHARMATIMES
    16 Jun 2021
    Share Share